SGX:BSLHealthcare
Assessing Raffles Medical Group (SGX:BSL) Valuation After Strong 2025 Results And Proposed Final Dividend
Raffles Medical Group (SGX:BSL) is back in focus after reporting full year 2025 results and proposing a final ordinary dividend of 3.0 Singapore cents per share, subject to shareholder approval in April 2026.
See our latest analysis for Raffles Medical Group.
The earnings and dividend announcement comes after a mixed share price run, with a 1 month share price return of 3.5% and a 3 month share price return of 4.6%. However, the 3 year total shareholder return shows a 17.2% decline,...